A Phase I, Open-Label, Randomized, Four Period Crossover Drug Interaction Study to Evaluate the Pharmacokinetic Profiles of VYVANSE and ADDERALL XR When Each is Administered Alone and in Combination With the Proton Pump Inhibitor Prilosec OTC in Healthy Adult Volunteers.

Trial Profile

A Phase I, Open-Label, Randomized, Four Period Crossover Drug Interaction Study to Evaluate the Pharmacokinetic Profiles of VYVANSE and ADDERALL XR When Each is Administered Alone and in Combination With the Proton Pump Inhibitor Prilosec OTC in Healthy Adult Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Nov 2009

At a glance

  • Drugs Lisdexamfetamine; Mixed amfetamine salts; Omeprazole
  • Indications Affective disorders; Gastrointestinal disorders
  • Focus Pharmacokinetics
  • Sponsors Shire
  • Most Recent Events

    • 19 Jun 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 22 May 2009 Results were announed in a Shire media release.
    • 28 Apr 2009 Results were presented at the International Congress on Clinical Pharmacy, according to a Shire media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top